Literature DB >> 23723068

Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation.

Sarah A Scott1, Yun Xiang, Thomas P Mathews, Hyekyung P Cho, David S Myers, Michelle D Armstrong, Keri A Tallman, Matthew C O'Reilly, Craig W Lindsley, H Alex Brown.   

Abstract

Phosphatidic acid (PA) is a lipid second messenger located at the intersection of several lipid metabolism and cell signaling events including membrane trafficking, survival, and proliferation. Generation of signaling PA has long been primarily attributed to the activation of phospholipase D (PLD). PLD catalyzes the hydrolysis of phosphatidylcholine into PA. A variety of both receptor-tyrosine kinase and G-protein-coupled receptor stimulations have been shown to lead to PLD activation and PA generation. This study focuses on profiling the PA pool upon P2Y6 receptor signaling manipulation to determine the major PA producing enzymes. Here we show that PLD, although highly active, is not responsible for the majority of stable PA being produced upon UDP stimulation of the P2Y6 receptor and that PA levels are tightly regulated. By following PA flux in the cell we show that PLD is involved in an initial increase in PA upon receptor stimulation; however, when PLD is blocked, the cell compensates by increasing PA production from other sources. We further delineate the P2Y6 signaling pathway showing that phospholipase Cβ3 (PLCβ3), PLCδ1, DGKζ and PLD are all downstream of receptor activation. We also show that DGKζ is a novel negative regulator of PLD activity in this system that occurs through an inhibitory mechanism with PKCα. These results further define the downstream events resulting in PA production in the P2Y6 receptor signaling pathway.

Entities:  

Keywords:  DAG Kinase; Diacylglycerol; Lipidomics; Phosphatidic Acid; Phospholipase D; Protein Kinase C (PKC); Purinergic Receptor

Mesh:

Substances:

Year:  2013        PMID: 23723068      PMCID: PMC3711313          DOI: 10.1074/jbc.M113.451708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  G-protein-coupled receptors at a glance.

Authors:  Wesley K Kroeze; Douglas J Sheffler; Bryan L Roth
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

2.  Molecular cloning and characterization of a novel human diacylglycerol kinase zeta.

Authors:  M Bunting; W Tang; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

3.  Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits.

Authors:  A V Smrcka; P C Sternweis
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

4.  Cloning and characterization of phospholipase D from rat brain.

Authors:  S K Park; J J Provost; C D Bae; W T Ho; J H Exton
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

5.  Kinetic analysis of a mammalian phospholipase D: allosteric modulation by monomeric GTPases, protein kinase C, and polyphosphoinositides.

Authors:  Lee G Henage; John H Exton; H Alex Brown
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

6.  Phospholipase D2 is localized to the rims of the Golgi apparatus in mammalian cells.

Authors:  Zachary Freyberg; Sylvain Bourgoin; Dennis Shields
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

7.  Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization.

Authors:  W C Colley; T C Sung; R Roll; J Jenco; S M Hammond; Y Altshuller; D Bar-Sagi; A J Morris; M A Frohman
Journal:  Curr Biol       Date:  1997-03-01       Impact factor: 10.834

8.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

9.  Regulation of phospholipase D in HL-60 granulocytes. Activation by phorbol esters, diglyceride, and calcium ionophore via protein kinase- independent mechanisms.

Authors:  M M Billah; J K Pai; T J Mullmann; R W Egan; M I Siegel
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

10.  Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling.

Authors:  Bai Luo; Stephen M Prescott; Matthew K Topham
Journal:  J Cell Biol       Date:  2003-03-10       Impact factor: 10.539

View more
  12 in total

1.  Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition.

Authors:  Thomas H Oguin; Shalini Sharma; Amanda D Stuart; Susu Duan; Sarah A Scott; Carrie K Jones; J Scott Daniels; Craig W Lindsley; Paul G Thomas; H Alex Brown
Journal:  J Biol Chem       Date:  2014-07-27       Impact factor: 5.157

2.  Measuring Phospholipase D Enzymatic Activity Through Biochemical and Imaging Methods.

Authors:  F Philip; E E Ha; M A Seeliger; M A Frohman
Journal:  Methods Enzymol       Date:  2016-10-22       Impact factor: 1.600

Review 3.  Chemical modulation of glycerolipid signaling and metabolic pathways.

Authors:  Sarah A Scott; Thomas P Mathews; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  Biochim Biophys Acta       Date:  2014-01-15

4.  The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D.

Authors:  Francis Speranza; Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

5.  Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells.

Authors:  Ronald C Bruntz; Harry E Taylor; Craig W Lindsley; H Alex Brown
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

6.  Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System Penetrance.

Authors:  Tricia L May-Dracka; Fang Gao; Brian T Hopkins; Xiaoping Hronowski; TeYu Chen; Jayanth V Chodaparambil; Claire M Metrick; Mike Cullivan; Istvan Enyedy; Maciej Kaliszczak; Mark W Kankel; Isaac Marx; Mackenzie A Michell-Robinson; Param Murugan; P Rajesh Kumar; Michael Rooney; Eli Schuman; Anindya Sen; Ti Wang; Tao Ye; Emily A Peterson
Journal:  ACS Med Chem Lett       Date:  2022-03-03       Impact factor: 4.632

7.  Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.

Authors:  Thomas P Mathews; Salisha Hill; Kristie L Rose; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

Review 8.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

9.  Phosphatidylinositol 4-phosphate is a major source of GPCR-stimulated phosphoinositide production.

Authors:  Rafael Gil de Rubio; Richard F Ransom; Sundeep Malik; David I Yule; Arun Anantharam; Alan V Smrcka
Journal:  Sci Signal       Date:  2018-09-11       Impact factor: 8.192

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.